AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05032872 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Exergame Treatment Group
Description: * Physical activity tracking, walk to grow flowers and plant their own garden~* Follow workout tutorials~* Daily steps tracked by Fitbit and workout log tracked by the app~* Daily reminders to wear Fitbit, use the app, and share stories to unlock new flowers to grow~* Includes social features: like, reply, and see other's stories, and share their stories; Access to other people's gardens~* In-app rewards (unlock new flowers to grow each week) if participants post stories
Study NCT05032872 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: * Physical activity tracking, walk to grow flowers and plant their own garden~* Follow workout tutorials~* Daily steps tracked by Fitbit and workout log tracked by the app~* Daily reminders to wear Fitbit and use the app
Study NCT05085171 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhanced care package
Description: The intervention is an improved package of care for patients with advanced HIV disease with point of care CD4 testing, more sensitive screening tests for opportunistic infections and more intensive pre-emptive treatment for opportunistic infections
Study NCT06371638 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: General anaesthesia for subjects in Group D was maintained by target-controlled infusion (TCI) dexmedetomidine (Dyck mode) with target plasma of 1 ng/ml
Study NCT06371638 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: General anaesthesia for subjects in Group D was maintained by target-controlled infusion (TCI) dexmedetomidine (Dyck mode) with target plasma of 1 ng/ml
Study NCT06371638 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Description: General anaesthesia for subjects in Group I was maintained by inhalation anaesthesia using sevoflurane at 0.8% concentration.
Study NCT06371638 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: General anaesthesia for subjects in Group I was maintained by inhalation anaesthesia using sevoflurane at 0.8% concentration.
Study NCT04650542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HBI-3000
Description: small molecule, multi-ion channel blocker
Study NCT04650542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine
Description: serotonin uptake inhibitor, CYP2D6 inhibitor
Study NCT06256328 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONO-4578
Description: Specified dose, once daily
Study NCT06256328 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Specified dose on specified days
Study NCT06256328 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oxaliplatin
Description: Specified dose on specified days
Study NCT06256328 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Specified dose on specified days
Study NCT06256328 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Capecitabine
Description: Specified dose on specified days
Study NCT06256328 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S-1
Description: Specified dose on specified days
Study NCT06256328 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: S-1
Description: Specified dose on specified days
Study NCT06256328 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Specified dose on specified days
Study NCT06256328 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nivolumab
Description: Specified dose on specified days
Study NCT06256328 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Specified dose, once daily
Study NCT05416944 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personalized blood pressure management
Description: Personalized blood pressure management: Intraoperative mean arterial pressure will be maintained at least at the mean nighttime mean arterial pressure (assessed using preoperative automated blood pressure monitoring) with a minimum mean arterial pressure of 65 mmHg, and maximum mean arterial pressure of 110 mmHg.
Study NCT04646967 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacain
Description: See active comparator description
Study NCT04646967 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacain
Description: See active comparator description
Study NCT04646967 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: See active comparator description
Study NCT04646967 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Description: See active comparator description
Study NCT04646967 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: See active comparator description
Study NCT04646967 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: See active comparator description
Study NCT04646967 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen
Description: See active comparator description
Study NCT04646967 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Description: See active comparator description
Study NCT04646967 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketorolac
Description: See experimental arm description
Study NCT05591261 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ePREP
Description: 6-session online psychoeducational program with supporting coach calls
Study NCT04864262 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Photovoice
Description: Photovoice is a method that uses photographs and dialogue to share experiences, understand an issue and promote positive change. Group meetings will be held four times throughout the photovoice intervention. The goals of the group meetings are to share knowledge about falls and fall prevention, identify commonalities in the issues raised by the participants, and discuss ways in which these issues could be addressed, both at individual and societal levels. For two photo assignments, participants will be asked to take 4-6 pictures for an assigned question. The question for photo assignment #1 will be 'What decreases your likelihood of falling?' The question for photo assignment #2 will be 'How do you reduce the risk of falling so that you can participate in meaningful activities?' Following each photo assignment, participants will complete an individual semi-structured interview with the peer mentor and the research trainee, who will have a background in physical or occupational therapy.
Study NCT06310408 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: nasal mask
Description: Give interface nasal mask
Study NCT06310408 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: nasal prong
Description: give interface nasal prong
Study NCT06098989 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Radio frequency ablation
Description: Radio frequency ablation
Study NCT05981924 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Perioperative Music Therapy
Description: Music therapist will play customized music in the perioperative period on the basis of oxycodone analgesia
Study NCT05415306 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attention Bias Modification
Description: Attention bias modification (ABM) is a procedure for treatment of depression, with the intention of supplementing cognitive behavioural therapy (CBT) or as a treatment on its own. ABM procedures modify attention biases in emotional disorders, resulting in subjects learning to deploy their attention toward the more positive stimuli (Jonassen et al., 2018). A computerized attention bias modification intervention for depression involves repeatedly redirecting the attention of the subject away from emotionally relevant threat cues, and towards neutral (non-threatening) stimuli (Amir et al., 2009). The location of the probe will replace the relatively positive stimulus in the pair with 100% probability.
Study NCT05415306 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Deep-breathing training
Description: In most deep breathing studies, participants are required to alter their breathing pattern to a specific frequency for a specific duration of time. In the present study, participants will be required to perform deep-breathing at a rate of 6 breaths per minute for 9 minutes.
Study NCT05415306 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham Training
Description: This condition is identical to the Attention Bias Modification condition with the except of the location of the probe, which replaces the positive, negative, and neutral stimuli with equal probability. This control procedure is not expected to modify any underlying biases present.
Study NCT05634655 — intervention group
Intervention type: OTHER
Intervention: no interventions between two groups
Description: no interventions between two groups
Study NCT05626569 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-1 combined with SBRT
Description: Anti-PD1 monoclonal antibody combined with SBRT. The SBRT defined as the radiation prescription with single dose equal or over 4Gy and the fractions less or equal to 10 fractions. BED equal or over 50Gy is required.
Study NCT06441370 — intervention group
Intervention type: PROCEDURE
Intervention: waterbirth
Description: waterbirth: laboured for all or part of the first stage of labour and remained in the water for birth of newborn
Study NCT05401877 — intervention group
Intervention type: PROCEDURE
Intervention: therapies for breast cancer
Description: the type of tumor removal surgery, combined therapy
Study NCT06280040 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Clinical examination and multimodal ocular imaging
Description: Imaging consists of sonography, fundus photography, oximeter, optical coherence tomography angiography, and Microperimetry.
Study NCT06333353 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Real RepetitiveTranscranial Magnetic Stimulation 5 sessions
Description: 5 consecutive treatment sessions will be provided using a protocol based on the updated guideline (Lefaucheur, 2014) and on Pinot-Monange et al. (2019). Each treatment session will last approximately 30 minutes.~Acceptability, adverse events and side effects will be recorded after each session, while the researchers will also record the total treatment time, difficulties encountered during implementation, and any modifications to the intervention.
Study NCT06333353 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham RepetitiveTranscranial Magnetic Stimulation 5 sessions
Description: 5 consecutive sham treatment sessions will be provided using a protocol based on the updated guideline (Lefaucheur, 2014) and on Pinot-Monange et al. (2019). Each treatment session will last approximately 30 minutes.~Acceptability, adverse events and side effects will be recorded after each session, while the researchers will also record the total treatment time, difficulties encountered during implementation, and any modifications to the intervention
Study NCT06333353 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Real RepetitiveTranscranial Magnetic Stimulation 10 sessions
Description: 10 consective treatment sessions will be provided using a protocol based on the updated guideline (Lefaucheur, 2014) and on Pinot-Monange et al. (2019). Each treatment session will last approximatly 30 minutes.~Acceptability, adverse events and side effects will be recorded after each session, while the researchers will also record the total treatment time, difficulties encountered during implementation, and any modifications to the intervention.
Study NCT06333353 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham RepetitiveTranscranial Magnetic Stimulation 10 sessions
Description: 10 consective sham treatment sessions will be provided using a protocol based on the updated guideline (Lefaucheur, 2014) and on Pinot-Monange et al. (2019). Each treatment session will last approximatly 30 minutes.~Acceptability, adverse events and side effects will be recorded after each session, while the researchers will also record the total treatment time, difficulties encountered during implementation, and any modifications to the intervention.
Study NCT06000033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disitamab Vedotin+Anlotinib
Description: Disitamab Vedotin:2 mg/kg，ivgtt，d1-14/28day/cycle Anlotinib: 12mg once daily (taken before meals) orally, continuously for 2 weeks followed by a 1-week break. Each cycle consists of 21 days.
Study NCT05216159 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HAPA behavioural counselling + weekly HAPA worksheets
Description: Behavioural counselling grounded in the Health Action Process Approach (HAPA; ie., action planning and coping planning) paired with weekly HAPA based worksheets delivered through a mobile application, SEMA3, to reduce consecutive workplace sedentary behaviour.
Study NCT05181371 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound Guided ESP Block with Programmed Intermittent Bolus (PIB) for VATS
Description: Programmed Intermittent Bolus (PIB) of Levobupivacaine
Study NCT05181371 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound Guided ESP Block with Continuous Infusion (CI) for VATS
Description: Continuous Infusion (CI) of Levobupivacaine
Study NCT05419973 — intervention group
Intervention type: OTHER
Intervention: Anthropometric measurement for pregnant women
Description: Weight, length, upper arm circumference
Study NCT05419973 — intervention group
Intervention type: OTHER
Intervention: Anthropometric measurement for infants
Description: birth weight, length, head circumference, nutritional status
Study NCT05419973 — intervention group
Intervention type: OTHER
Intervention: Blood sampling
Description: 3 ml of blood will be taken, 1,5 ml each to measure the complete blood count, and other 1,5 ml to measure ferritin, Fe serum, vitamin D levels, vitamin D receptors, IL-6 and IL-10.
Study NCT06166563 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Program
Description: The intervention includes an individualized exercise program in Frequency, Intensity, Time, and Type (FITT).
Study NCT05190627 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Loratadine
Description: Loratadine 10mg/day added to rapamycin for 12 months
Study NCT05190627 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo 10mg/day added to rapamycin for 12 months
Description: Placebo in the same type of capsule than the experimental drug
Study NCT06090838 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Balloon Pulmonary Angioplasty (BPA)
Description: A balloon pulmonary angioplasty is a minimally invasive intervention procedure to remove blood clots from the pulmonary arteries.
Study NCT06409429 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nimotuzumab
Description: Patients will receive Nimotuzumab 400 mg weekly or Nimotuzumab 600 mg on Day 1 and 8 of a 21-day cycle, up to 6 months.
Study NCT06409429 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: GX
Description: Patients will receive GX as adjuvant therapy for 6 months. Gemcitabine will be delivered as a 1000 mg/m² intravenous infusion administered on Day 1 and 8 of a 21-day cycle. Capecitabine 2000mg/m²/day will be administered orally for 14 days followed by 7 days' rest.
Study NCT06409429 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GX
Description: Patients will receive GX as adjuvant therapy for 6 months. Gemcitabine will be delivered as a 1000 mg/m² intravenous infusion administered on Day 1 and 8 of a 21-day cycle. Capecitabine 2000mg/m²/day will be administered orally for 14 days followed by 7 days' rest.
Study NCT06409429 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will receive placebo 400 mg weekly or placebo 600 mg on Day 1 and 8 of a 21-day cycle, up to 6 months.
Study NCT05774132 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound guided Subgluteal sciatic nerve block
Description: Patients will be positioned in lateral decubitus and the ultrasound scanning for the sciatic nerve in the subgluteal region will be started between the two bony landmarks (greater trochanter and ischial tuberosity ) using high frequency linear probe then approached via 5 cm block needle under ultrasound guidance after which bupivacaine 0.25% (0.3 ml/kg) will be administered in increments .
Study NCT05774132 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound guided Caudal block
Description: Patients will be positioned in lateral decubitus and their sacral hiatus will be palpated under the scanning of the ultrasound using high frequency linear probe then approached via 5 cm block needle that pierce the sacrococcygeal ligament then will be advanced to caudal canal under ultrasound guidance after which bupivacaine 0.25% (1 ml/kg) will be administered in increments.
Study NCT05745701 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PF-07081532
Description: Oral Tablet
Study NCT05745701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07081532
Description: Oral Tablet
Study NCT05745701 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Description: Oral Solution
Study NCT05745701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: Oral Capsule
Study NCT05694013 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Roche DPM Module
Description: Participants will be trained in the use of the Roche DPM Module, which they will use alongside local SOC support
Study NCT05694013 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab SC
Description: Participants will receive atezolizumab SC for 16 cycles (cycle length = 21 days)
Study NCT05694013 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Local SOC support
Description: Participants will receive local SOC support
Study NCT05478889 — intervention group
Intervention type: PROCEDURE
Intervention: Minimally invasive pancreatoduodenectomy
Description: Whipple's procedure using minimally invasive (laparoscopic/robotic) techniques
Study NCT05381545 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: laser puncture, energy expenditure programming, and low-calories recommended diet programming
Description: This research group will receive, for 12 weeks, energy expenditure program (Pilates exercise, managed 5 times per week) combined with low calorie diet .This research group will receive an additional laser puncture (with 3-time per-week design). The following points will be directly contacted by laser, for two minutes: GB34\&28, ST25\&36\&40, SP6, and CV4\&9\&12.
Study NCT05381545 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: energy expenditure programming and low-calories recommended diet programming
Description: This research group will receive, for 12 weeks, energy expenditure program (Pilates exercise, managed 5 times per week) combined with low calorie diet.
Study NCT04834544 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: DCVAC/OvCa
Description: An active cellular immunotherapy product containing autologous dendritic cells that are generated ex vivo from patient's monocytes and apoptotic tumor cells prepared from tumor cell lines
Study NCT04834544 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06220136 — intervention group
Intervention type: DEVICE
Intervention: TOFscan monitoring
Description: observation and data recording
Study NCT06462703 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tablet-based neurorehabilitation with myReha
Description: The myReha therapy software provides cognitive therapy in the domains attention, executive functions, perception, language, speech, arithmetics, and memory. It automatically creates weekly plans that are individually tailored to a patient's abilities and provides real-time feedback when completing tasks. Intelligent algorithms ensure that the exercises always remain at the optimum level of difficulty.
Study NCT05116813 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dipraglurant
Description: Oral 50 mg and 100 mg tablet
Study NCT05052021 — intervention group
Intervention type: OTHER
Intervention: Recent or Peri-Operative Covid19 Infection
Description: No intervention will be done. The groups will be differentiated based on whether they had recent or peri-operative Covid19 infection (group 1), or whether they have had no or previous Covid19 infection (Group 2)
Study NCT05352659 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Face-to-face and online LGBTQ+ training
Description: The intervention consists of Organization-level technical assistance in regard to LGBTQ climate of the organization AND Clinician-level face-to-face virtual workshop LGBTQ competency training, virtual clinical consultations, and links to publicly available LGBTQ training.
Study NCT05352659 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: On-line training
Description: This study arm receives only links to publicly available on-line LGBTQ training.